PROphylaxis for paTiEnts at risk of COVID-19 infecTion (PROTECT-V)

BACKGROUND: Despite the introduction of vaccination, there remains a need for pre-exposure prophylactic agents against SARS-CoV-2. Several patient groups are more vulnerable to SARS-CoV-2 infection by virtue of underlying health conditions, treatments received or suboptimal responses to vaccination....

Descripción completa

Detalles Bibliográficos
Autores principales: Humphrey, Toby J. L., Dosanjh, Davinder, Hiemstra, Thomas F., Richter, Alex, Chen-Xu, Michael, Qian, Wendi, Jha, Vivekanand, Gatley, Katrina, Adhikari, Rakshya, Dowling, Francis, Smith, Rona M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009350/
https://www.ncbi.nlm.nih.gov/pubmed/36915199
http://dx.doi.org/10.1186/s13063-023-07128-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009350/
https://www.ncbi.nlm.nih.gov/pubmed/36915199
http://dx.doi.org/10.1186/s13063-023-07128-z

Ejemplares similares